Traders should expect high volatility ahead of the May 4 appeal deadline and May 6 suspension date. If the appeal is denied or the hearing fails, delisting would likely trigger a sharp sell-off in an already distressed stock. Monitor for any reverse split announcement or capital raise as potential compliance strategies.
CRIS drugs
CRIS drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 4 $11.60entry
- T+1 · 7mo ago −1.72%α −2.53% · $11.40
- T+5 · 6mo ago −5.17%α −8.14% · $11.00
- T+20 · 6mo ago −13.79%α −19.58% · $10.00
- T+60 · 4mo ago −57.07%α −58.93% · $4.98
Price Chart
How similar events traded
Executive Summary
Curis received a Nasdaq delisting determination letter on April 27, 2026, because its common stock bid price closed below $1.00 for 30 consecutive business days. The company intends to appeal by requesting a hearing before May 4, 2026, which would stay the suspension scheduled for May 6, but there is no assurance the appeal will succeed. This filing follows a prior discretionary panel monitor period, meaning Curis has limited procedural flexibility to regain compliance.
Key Facts
- Nasdaq issued a Delist Determination Letter on April 27, 2026 for non-compliance with the $1.00 minimum bid price rule (Listing Rule 5550(a)(2)).
- Stock had closed below $1.00 for 30 consecutive business days.
- Trading suspension scheduled for May 6, 2026 unless an appeal is filed by May 4, 2026.
- Company was already under a one-year Discretionary Panel Monitor (since Feb 3, 2026), limiting its ability to request additional compliance periods.
- Company intends to request a hearing to stay delisting, but success is uncertain.
- Market cap is approximately $24M, making the company highly vulnerable to delisting consequences.
Financial Impact
Delisting would severely reduce institutional ownership and liquidity for a $24M market cap company. No specific financial figures provided in filing.
Risk Factors
- Delisting would cut off institutional access and severely reduce liquidity.
- Company is already under a Panel Monitor, limiting its ability to negotiate compliance extensions.
- No guarantee the Nasdaq hearing panel will grant continued listing.
- At $24M market cap, the company has limited financial flexibility to engineer a compliance solution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001108205-26-000056 |
| Document: 0001108205-26-000056-index-headers.html | 0001108205-26-000056 |
| Document: 0001108205-26-000056-index.html | 0001108205-26-000056 |
| Document: 0001108205-26-000056.txt | 0001108205-26-000056 |
Track record
18 reports on CRIS
6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
- Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
- Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
- Nov 2, 202614d ago DEF 14A Neutral 4/10 Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
- Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers